Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Immunotherapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Melanoma 4 Esophageal Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Rectal Neoplasms 2 Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Muscle-invasive Bladder Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Limited Stage Small Cell Lung Cancer 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡